Stay updated on Emricasan in NASH Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the full study record, indicating restricted access to the page and showing a minimal header with a Home link.
    Difference
    17%
    Check dated 2026-09-23T00:59:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, replacing the previous Revision: v3.6.6. This signals a new site version deployment rather than changes to the study details, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-09-16T00:15:57.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, signaling a minor update to the page’s underlying template or CMS. This change does not affect the study details, content, or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-09-01T19:35:39.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.4 to v3.6.5. This signifies a minor build/content update and does not change the study information presented.
    Difference
    0.0%
    Check dated 2026-08-11T20:38:47.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.3 to v3.6.4, indicating a small update to the page's versioning. It does not modify any study data or displayed content.
    Difference
    0.0%
    Check dated 2026-07-28T15:15:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Steatotic Liver Disease has been added and Fatty Liver Disease removed from the page's keyword taxonomy, reflecting updated naming conventions for liver conditions and affecting how the study is indexed and discovered.
    Difference
    0.1%
    Check dated 2026-07-14T06:42:24.000Z thumbnail image

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.